Aligos Therapeutics Inc. (ALGS) Misses Q1 EPS by 221c

Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q1 EPS of ($2.21). Revenue for the quarter came in at $2.83 million.

For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
• NVIDIA (NVDA) Pauses Revenue-Sharing Deals With AI Cloud Companies - WSJ